Human urinary kallindinogenase therapy for acute ischemic stroke according to Chinese ischemic stroke subclassification: Clinical efficacy and risk factors-Reference-Cited by-同舟云学术

Human urinary kallindinogenase therapy for acute ischemic stroke according to Chinese ischemic stroke subclassification: Clinical efficacy and risk factors

Published:2019-12-02 Issue:1 Volume:10 Page:
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain Behav

Author:

Chen Si‐Qia¹,Mao Dong‐Yang²,Wei Dun‐Can³,He Wen‐Zhen¹^ORCID

Affiliation:

1. Department of Neurology First Affiliated Hospital of Shantou University Medical College Shantou China

2. Clinical Pharmacy First Affiliated Hospital of Shantou University Medical College Shantou China

3. Department of Pharmacy First Affiliated Hospital of Shantou University Medical College Shantou China

Publisher

Wiley

Subject

Behavioral Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.1461

Reference27 articles.

1. The Kallikrein-Kinin System In Humans

2. Classifying Ischemic Stroke, from TOAST to CISS

3. Human Urinary Kallidinogenase Suppresses Cerebral Inflammation in Experimental Stroke and Downregulates Nuclear Factor-κB

4. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit

5. Road to clinical research of new drug ‐ clinical research of kalikang (eureklin for injection);Deyun D.;China Prescription Drug,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effects of human urinary kallidinogenase against corticospinal tract damage in acute ischemic stroke patients;NeuroReport;2024-03-12

2. Dazhu Hongjingtian Injection for Ischemic Stroke: Protocol for a Prospective, Multicenter Observational Study;JMIR Research Protocols;2023-12-22

3. Recent Advances and Therapeutic Implications of 2-Oxoglutarate-Dependent Dioxygenases in Ischemic Stroke;Molecular Neurobiology;2023-12-02

4. Dazhu Hongjingtian Injection for Ischemic Stroke: Protocol for a Prospective, Multicenter Observational Study (Preprint);2023-09-05

5. Efficacy and Safety of Human Urinary Kallidinogenase for Acute Ischemic Stroke;The Neurologist;2023-08-03